Variant report

Variant	nsv962289
Chromosome Location	chr17:20805654-20810355
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:23)
CpG islands
(count:183)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:23 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr17:20810255-20812637	K562	blood:	n/a	chr17:20811749-20811762
2	CEBPB	chr17:20806234-20806434	K562	blood:	n/a	n/a
3	MYC	chr17:20806922-20807114	MCF10A-Er-Src	breast:	n/a	n/a
4	POLR2A	chr17:20808117-20808137	K562	blood:	n/a	n/a
5	POLR2A	chr17:20809189-20809198	H1-hESC	embryonic stem cell:	n/a	n/a
6	POLR2A	chr17:20805187-20806116	H1-hESC	embryonic stem cell:	n/a	n/a
7	POLR2A	chr17:20809200-20809210	H1-hESC	embryonic stem cell:	n/a	n/a
8	POLR2A	chr17:20810257-20810794	HepG2	liver:	n/a	n/a
9	POLR2A	chr17:20805584-20806233	H1-hESC	embryonic stem cell:	n/a	n/a
10	POLR2A	chr17:20807099-20807288	K562	blood:	n/a	n/a
11	POLR2A	chr17:20809806-20809966	H1-hESC	embryonic stem cell:	n/a	n/a
12	POLR2A	chr17:20810275-20815715	K562	blood:	n/a	n/a
13	POLR2A	chr17:20809746-20809918	K562	blood:	n/a	n/a
14	POLR2A	chr17:20807210-20807265	HepG2	liver:	n/a	n/a
15	POLR2A	chr17:20807125-20807375	H1-hESC	embryonic stem cell:	n/a	n/a
16	POLR2A	chr17:20805450-20806120	K562	blood:	n/a	n/a
17	POLR2A	chr17:20805848-20806305	K562	blood:	n/a	n/a
18	POLR2A	chr17:20809134-20809154	HepG2	liver:	n/a	n/a
19	POLR2A	chr17:20807238-20807239	H1-hESC	embryonic stem cell:	n/a	n/a
20	POLR2A	chr17:20807246-20807362	H1-hESC	embryonic stem cell:	n/a	n/a
21	POLR2A	chr17:20809164-20809173	HepG2	liver:	n/a	n/a
22	POLR2A	chr17:20805696-20806117	K562	blood:	n/a	n/a
23	POLR2A	chr17:20807572-20807700	H1-hESC	embryonic stem cell:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:20805664-20805714	SK-N-SH	brain:	n/a
2	chr17:20805904-20805954	MCF10A-Er-Src	breast:	n/a
3	chr17:20805904-20805954	AG09309	skin:	n/a
4	chr17:20805664-20805714	AG09309	skin:	n/a
5	chr17:20805904-20805954	GM12892	blood:	n/a
6	chr17:20805664-20805714	SKMC	muscle:	n/a
7	chr17:20805904-20805954	HL-60	blood:	n/a
8	chr17:20805664-20805714	HRPEpiC	eye:	n/a
9	chr17:20805664-20805714	AG09319	gingival:	n/a
10	chr17:20805904-20805954	BE2_C	brain:	n/a
11	chr17:20805664-20805714	AG04450	lung:	fetal
12	chr17:20805904-20805954	HMEC	breast:	n/a
13	chr17:20805664-20805714	Jurkat	blood:	n/a
14	chr17:20805664-20805714	ProgFib	skin:	n/a
15	chr17:20805664-20805714	U87	brain:	n/a
16	chr17:20805904-20805954	Jurkat	blood:	n/a
17	chr17:20809014-20809064	HMEC	breast:	n/a
18	chr17:20805904-20805954	T-47D	breast:	n/a
19	chr17:20809014-20809064	IMR90	lung:	fetal
20	chr17:20805664-20805714	NB4	blood:	n/a
21	chr17:20805664-20805714	HCPEpiC	choroid plexus:	n/a
22	chr17:20805664-20805714	HMEC	breast:	n/a
23	chr17:20805904-20805954	HRE	kidney:	n/a
24	chr17:20805904-20805954	NHBE	bronchial:	n/a
25	chr17:20805664-20805714	GM12891	blood:	n/a
26	chr17:20805904-20805954	LNCaP	prostate:	n/a
27	chr17:20809014-20809064	MCF10A-Er-Src	breast:	n/a
28	chr17:20805904-20805954	HPAEpiC	pulmonary alveolar:	n/a
29	chr17:20805664-20805714	HCM	heart:	n/a
30	chr17:20805664-20805714	K562	blood:	n/a
31	chr17:20809014-20809064	AG09309	skin:	n/a
32	chr17:20809014-20809064	GM06990	blood:	n/a
33	chr17:20805904-20805954	U87	brain:	n/a
34	chr17:20805664-20805714	BJ	skin:	n/a
35	chr17:20809014-20809064	NHBE	bronchial:	n/a
36	chr17:20805904-20805954	AG10803	skin:	n/a
37	chr17:20805904-20805954	AG09319	gingival:	n/a
38	chr17:20809014-20809064	HEK293	kidney:	embryo
39	chr17:20809014-20809064	HRE	kidney:	n/a
40	chr17:20805904-20805954	NHDF-neo	bronchial:	n/a
41	chr17:20805904-20805954	GM19239	blood:	n/a
42	chr17:20805664-20805714	PANC-1	pancreas:	n/a
43	chr17:20809014-20809064	T-47D	breast:	n/a
44	chr17:20805904-20805954	PFSK-1	brain:	n/a
45	chr17:20805664-20805714	GM06990	blood:	n/a
46	chr17:20805664-20805714	Hepatocyte	liver:	n/a
47	chr17:20805904-20805954	PrEC	prostate:	n/a
48	chr17:20805904-20805954	ProgFib	skin:	n/a
49	chr17:20809014-20809064	AG04449	skin:	fetal
50	chr17:20809014-20809064	H1-hESC	embryonic stem cell:	embryo

No data

Variant related genes	Relation type
RNASEH1P1	TF binding region
RNASEH1P1	CpG island

Extended variants
information (count: 235 )
Associated
traits (count: 150 )

Variant overlapped rSNPs/rCNVs (count:235 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs113009777	chr17:20805657-20805658	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs529024455	chr17:20805662-20805663	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs547496314	chr17:20805664-20805665	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs7226350	chr17:20805668-20805669	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs142187783	chr17:20805671-20805672	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs551398706	chr17:20805685-20805686	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs150767207	chr17:20805696-20805697	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs112570501	chr17:20805697-20805698	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs555761396	chr17:20805707-20805708	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs573683819	chr17:20805708-20805709	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs7224477	chr17:20805764-20805765	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs553047600	chr17:20805767-20805768	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs17690697	chr17:20805784-20805785	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs7211002	chr17:20805786-20805787	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs563842338	chr17:20805826-20805827	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs578042394	chr17:20805827-20805828	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs575863875	chr17:20805828-20805829	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs542928656	chr17:20805857-20805858	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs561697503	chr17:20805884-20805885	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs528883598	chr17:20805896-20805897	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs547520711	chr17:20805925-20805926	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs534384383	chr17:20805929-20805930	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs559452669	chr17:20805944-20805945	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs12325686	chr17:20805946-20805947	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs12325896	chr17:20805950-20805951	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs141965830	chr17:20805968-20805969	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs116228762	chr17:20805970-20805971	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs7211311	chr17:20805973-20805974	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs185169891	chr17:20805983-20805984	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs548856064	chr17:20805984-20805985	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs567369961	chr17:20806014-20806015	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs534652984	chr17:20806031-20806032	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs553059911	chr17:20806038-20806039	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs577679932	chr17:20806045-20806046	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs538199970	chr17:20806055-20806056	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs553460347	chr17:20806068-20806069	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs201435947	chr17:20806093-20806094	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs374409547	chr17:20806122-20806123	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs538882947	chr17:20806123-20806124	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs557558113	chr17:20806178-20806179	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs575731547	chr17:20806194-20806195	Weak transcription Strong transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs543342876	chr17:20806203-20806204	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs569425200	chr17:20806210-20806211	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs561562736	chr17:20806211-20806212	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs573691085	chr17:20806212-20806213	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs540996138	chr17:20806219-20806220	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs369401350	chr17:20806274-20806275	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs531923798	chr17:20806291-20806292	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs533078251	chr17:20806312-20806313	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs548830465	chr17:20806314-20806315	Weak transcription Strong transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:150)

Disease	PMID	Source
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17142309	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:29 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20798200-20811600	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr17:20798800-20806800	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr17:20800200-20811000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr17:20801800-20812200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr17:20802200-20807600	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr17:20803200-20806200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr17:20803200-20811400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr17:20803400-20805800	Weak transcription	HUES48 Cell Line	embryonic stem cell
9	chr17:20803400-20811200	Weak transcription	H1 Cell Line	embryonic stem cell
10	chr17:20803400-20811400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
11	chr17:20804200-20811800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
12	chr17:20805600-20806200	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr17:20805600-20806200	Enhancers	HUES6 Cell Line	embryonic stem cell
14	chr17:20805800-20806000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr17:20805800-20806000	Bivalent Enhancer	Fetal Muscle Leg	muscle
16	chr17:20805800-20806000	Bivalent Enhancer	Fetal Stomach	stomach
17	chr17:20806000-20806200	Bivalent Enhancer	Primary hematopoietic stem cells	blood
18	chr17:20806000-20806200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr17:20806200-20806400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
20	chr17:20806200-20806800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr17:20806200-20811000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr17:20806200-20811400	Weak transcription	HUES6 Cell Line	embryonic stem cell
23	chr17:20806800-20810200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr17:20807200-20811400	Weak transcription	HUES48 Cell Line	embryonic stem cell
25	chr17:20807600-20808200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
26	chr17:20808200-20809200	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr17:20809200-20810000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
28	chr17:20810000-20812800	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
29	chr17:20810200-20812600	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links